In this study, we report a novel role of TRIM25 in regulating metabolic pathways by mediating PPARγ ubiquitination and its proteasome-dependent degradation, suggesting that TRIM25 may be a potential therapeutic target in PPARγ-mediated metabolic diseases such as obesity and type 2 diabetes. Here, PPARG is linked to metabolic disease.